| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0399-8320(04)94995-0 |
| P698 | PubMed publication ID | 15213671 |
| P2093 | author name string | Olivier Rosmorduc | |
| Raoul Poupon | |||
| P2860 | cites work | Cystic fibrosis transmembrane conductance regulator (CFTR) gene defects in patients with primary sclerosing cholangitis | Q74485494 |
| Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat | Q77308908 | ||
| Identification of a nuclear receptor for bile acids | Q22010058 | ||
| FIC1, the protein affected in two forms of hereditary cholestasis, is localized in the cholangiocyte and the canalicular membrane of the hepatocyte | Q24291838 | ||
| Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol | Q24306058 | ||
| The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity | Q24630723 | ||
| The molecular genetics of familial intrahepatic cholestasis | Q24670001 | ||
| Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor | Q24683260 | ||
| Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis | Q28139039 | ||
| Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management | Q28141076 | ||
| Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking | Q28142016 | ||
| A unified nomenclature system for the nuclear receptor superfamily | Q28142509 | ||
| Exon-intron organization of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin-Johnson syndrome | Q28143088 | ||
| Differential Modulation of the Human Liver Conjugate Transporters MRP2 and MRP3 by Bile Acids and Organic Anions | Q28155855 | ||
| The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux | Q28186424 | ||
| Nuclear receptor minireview series | Q28207308 | ||
| BSEP: function and role in progressive familial intrahepatic cholestasis | Q28211441 | ||
| Role of multidrug resistance 3 deficiency in pediatric and adult liver disease: one gene for three diseases | Q28211448 | ||
| The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood | Q28213549 | ||
| MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis | Q28213568 | ||
| A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome | Q28240926 | ||
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity | Q28247292 | ||
| Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha | Q28273937 | ||
| Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy | Q28295646 | ||
| Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL | Q28354252 | ||
| Biliary lipid composition in cholesterol microlithiasis | Q28362634 | ||
| Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production | Q28379482 | ||
| Nuclear receptors and lipid physiology: opening the X-files | Q29619362 | ||
| Genetic basis of progressive familial intrahepatic cholestasis | Q33715915 | ||
| Molecular alterations in hepatocyte transport mechanisms in acquired cholestatic liver disorders | Q34081640 | ||
| Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis | Q34118792 | ||
| Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited | Q34146325 | ||
| Bile salt transporters: molecular characterization, function, and regulation | Q34186800 | ||
| Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion | Q34415865 | ||
| FIC1 disease: a spectrum of intrahepatic cholestatic disorders | Q34464148 | ||
| Bile salt transporters | Q34516267 | ||
| Mechanisms of hepatic transport of drugs: implications for cholestatic drug reactions | Q34643082 | ||
| Nuclear receptor regulation of hepatic function | Q34666809 | ||
| An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. | Q34732527 | ||
| Biliary cholesterol secretion by the twinned sterol half-transporters ABCG5 and ABCG8 | Q34796390 | ||
| Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): its impact on drug disposition | Q34983639 | ||
| A second heterozygous MDR3 nonsense mutation associated with intrahepatic cholestasis of pregnancy | Q35441702 | ||
| Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy | Q35595748 | ||
| A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation | Q37383640 | ||
| Involvement of multidrug resistance proteins (MDR) in the modulation of glucocorticoid response | Q38357628 | ||
| Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children | Q40457634 | ||
| Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. | Q40785589 | ||
| Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis | Q40883127 | ||
| Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi | Q43601204 | ||
| Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver | Q43601206 | ||
| Tauroursodesoxycholate-induced choleresis involves p38(MAPK) activation and translocation of the bile salt export pump in rats | Q43697146 | ||
| Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump | Q43899918 | ||
| Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1. | Q44053787 | ||
| ATP binding cassette G5 C1950G polymorphism may affect blood cholesterol concentrations in humans. | Q44130745 | ||
| Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles | Q44165186 | ||
| Trafficking and functional defects by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson syndrome | Q44190773 | ||
| Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement | Q44255121 | ||
| Comparison of the intestinal uptake of cholesterol, plant sterols, and stanols in mice | Q44299999 | ||
| Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity | Q44381534 | ||
| A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis | Q44387840 | ||
| ABCB4 gene mutation-associated cholelithiasis in adults | Q44532958 | ||
| Spontaneous cholecysto- and hepatolithiasis in Mdr2-/- mice: a model for low phospholipid-associated cholelithiasis. | Q44749286 | ||
| Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. | Q52541251 | ||
| Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. | Q54017726 | ||
| Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. | Q54118475 | ||
| Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. | Q54198574 | ||
| Molecular pathogenesis of cholestasis. | Q54344101 | ||
| Influence of polymorphisms within the CX3CR1 and MDR-1 genes on initial antiretroviral therapy response | Q57259756 | ||
| Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter GeneABCB1 | Q57840857 | ||
| Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? | Q69896715 | ||
| Effect of obstructive jaundice on the regulation of hepatic cholesterol metabolism in the rat. Disappearance of abcg5 and abcg8 mRNA after bile duct ligation | Q73143394 | ||
| Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors | Q74381357 | ||
| P433 | issue | 5 Suppl | |
| P407 | language of work or name | French | Q150 |
| P921 | main subject | genomics | Q222046 |
| P304 | page(s) | D112-20 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Gastroenterologie Clinique et Biologique | Q15756157 |
| P1476 | title | Hepatobiliary transporters: from genomics to diseases | |
| P478 | volume | 28 |
Search more.